Why the study?
Do lifestyle modification and pharmacotherapy for cardiovascular risk factors improve erectile dysfunction severity?
Population
740 participants from 6 randomized controlled clinical trials in 4 countries. Key inclusion: follow-up of at…
Design
Meta-analysis
Follow-up
at least 6 weeks
Authors
Loading...
Supports CV risk factor management in ED care; reinforces consensus from aggregated trial data.
Do lifestyle modification and pharmacotherapy for cardiovascular risk factors improve erectile dysfunction severity?
Lifestyle modification and pharmacotherapy targeting cardiovascular risk factors significantly improve sexual function in men with erectile dysfunction.
Bhanu Gupta (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: